Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task
NCT ID: NCT03837886
Last Updated: 2019-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
12 participants
INTERVENTIONAL
2019-10-20
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Sodium Bicarbonate on Exercise Performance
NCT06098794
Consistencies in Responses to Sodium Bicarbonate?
NCT02474628
Blood, Muscle and Exercise Responses to Sodium Bicarbonate Supplementation
NCT03505970
Acute Sodium Bicarbonate Supplementation in Athletes
NCT03810404
Effects of Novel Sodium Bicarbonate Ingestion of Buffering Capacity
NCT03813329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alkalosis group
The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of sodium bicarbonate
Sodium bicarbonate
The subjects should ingest 0.3g.kg of sodium bicarbonate 90 minutes before the beginning of the protocol task.
Placebo group
The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of Calcium Carbonate
Calcium carbonate
The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of Calcium Carbonate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sodium bicarbonate
The subjects should ingest 0.3g.kg of sodium bicarbonate 90 minutes before the beginning of the protocol task.
Calcium carbonate
The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of Calcium Carbonate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* respiratory (asthma, COPD), renal, metabolic, rheumatic and cardiovascular disorders;
* acid-base balance disorder;
* continuous use of some type of medication;
* use of high-protein supplementation and creatine supplementation;
* users of anabolic steroids.
20 Years
42 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marcelo Martins Kalytczak
UNKNOWN
University of Nove de Julho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fabiano Politti
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nove de Julho University
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FP001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.